Based on an intent-to-treat analysis , an objective response rate of 30 % ( 95 % confidence interval [ CI ] , 16.6-46 .5 ) was observed in the monotherapy arm , and 35.9 % ( 95 % CI , 21.2-52 .8 ) in the combination arm .